News | Oncology Diagnostics | October 30, 2017

Laser Scanner Detects Skin Cancer in Less Than 30 Seconds

A team of European scientists has developed the world’s first cancer scanner that detects blood vessels grown by a malignant melanoma with an infrared laser beam in 30 seconds

Laser Scanner Detects Skin Cancer in Less Than 30 Seconds

Image courtesy of VivoSight

cancer detection scanning patient

Image courtesy of VivoSight

 Photonics VivoSightDX OCT cancer detection screen

Image courtesy of VivoSight

October 30, 2017 — Current skin cancer diagnosis can last a number of weeks and be very upsetting. However, a new imaging system developed by a group of European scientists could dramatically speed up the process and reduce the need for debilitating sentinel-lymph node biopsies by placing real-time cancer diagnosis in the hands of a dermatologist.

Multiple stages of skin cancer diagnosis can involve visiting a GP, being sent to a dermatologist for a skin biopsy, waiting for laboratory analysis, having a sentinel lymph node biopsy under general anaesthetic, and then having more tests if the cancer has spread.

Now, using a handheld laser, a specialist can actually see under the skin at depths of 1 mm by creating a 3-D color image of the microscopic blood vessels in a process that takes around 30 seconds.

Employing a new and advanced version of optical coherence tomography (OCT), a photonics technique more commonly used in retina scans, the scanner captures 3-D images of the micro-structures under the skin with a harmless infrared laser beam.

Since melanomas need oxygen to grow and survive, they grow their own blood vessels. As the cancer develops and becomes more malignant, they become increasingly distorted and malformed, differing in appearance from healthy vessels.

Being able to detect and see these vessels in a suspicious lesion in real time has never been possible, until now, opening the possibility for dermatologists to make treatment decisions in an unrivalled timeframe.

Over 55,500 people in the world died from malignant melanoma of the skin in 2012 alone. While 2,459 deaths from melanoma skin cancer were recorded in the United Kingdom in 2014, an estimated 9,730 people will die of melanoma in the United States in 2017.

Melanomas produce their own blood vessels to feed and grow the tumor, so by revealing the microstructures in 3-D pictures the scanner show doctors how the cancer has developed.

A specialist can potentially determine on the spot, whether simply cutting it out is sufficient for a cure or whether further treatment with cancer drugs will be needed.

With their new device called VivoSight on the market, the European team ADVANCE (Automatic Detection of VAscular Networks for Cancer Evaluation) is aiming to reduce the time for treatment decision from a number of weeks to a matter of seconds, while removing the invasive nature of the appointment.

U.K. project leader Jon Holmes of Michelson Diagnostics Ltd, a key partner in the ADVANCE consortium, explained, “Every melanoma above a certain thickness could have spread to other parts of the body. At present, all patients with such melanomas have to wait for a sentinel lymph node biopsy performed in a hospital under general anesthesia to find out if it is spreading. This can take weeks to perform, is very expensive and can be debilitating for the patient.”

The ADVANCE team has employed a variant of OCT in its scanner called speckle-variance OCT or dynamic OCT (D-OCT), an advancement of OCT that is ideal for capturing movement.

Studying the ‘speckle’ or flicker of light patterns created by moving blood cells, the imaging device takes around four frames per second and compiles the images so that a clinician may tell where something has moved on the image from frame to frame.

“Using D-OCT we can see movement of blood against the solid tissue structures, something we have never been able to do before in a clinical setting. It’s like looking out at night and seeing cars’ headlights flowing along a motorway, only at depths of nanometers under the skin,” said Holmes.

While a sentinel node biopsy can cost in excess of €10,000 (~$13,000 U.S.), and with many hospitals performing hundreds per year, there is a growing concern and a need to find an alternative when over 80 percent of these operations turn out to be clear of any malignant growth, according to Holmes.

As well as its use in skin cancer diagnosis, the ability to see blood vessel networks with the ADVANCE technology has created a number of useful spin-off benefits.

“The scanner can image the blood vessels in healing wounds. This may have application for treatment of leg and foot chronic ulcers, when doctors want to know whether a wound is healing or requires a change in treatment, potentially reducing the number of amputations,” said Holmes. He added,

“ADVANCE technology may also help with burn victims, being able to give a doctor a quicker response time than the standard 15 days to determine whether a patient’s skin is healing and whether or not to give a skin graft.”

For more information: www.photonics21.org

Related Content

Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
X-ray Mammography Adoption to Skyrocket for Breast Cancer Detection
News | Mammography | October 08, 2018
Highly populated countries have traditionally been slow adopters of non-conventional business models, but a new Frost...
Body Vision Medical Announces Release of LungVision
Technology | Lung Cancer | October 05, 2018
Body Vision Medical, a medical device company specializing in lung cancer diagnostics, announced the launch of its...
Enterprise imaging has been a hot topic in radiology and healthcare information technology (IT) circles for the last several years as medical image acquisition has moved beyond the exclusive purview of radiology.
Feature | Enterprise Imaging | October 03, 2018 | By Jeff Zagoudis
Enterprise imaging has been a hot topic in radiology and healthcare information technology (IT) circles for the last...
Leica Biosystems Launches MammoPort Specimen Containment and Transport System
Technology | Breast Biopsy Systems | October 03, 2018
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system...
Adherence to Annual Lung Cancer Screening Needs Improvement
News | Lung Cancer | October 03, 2018
A study of adherence to annual low-dose computed tomography (LDCT) screening within the Veteran Health Administration...
Brainlab and Magic Leap Partner in Digital Surgery
News | Advanced Visualization | September 28, 2018
September 28, 2018 — Brainlab announced a strategic development partnership with Florida-based Magic Leap, a develope
Augusta University Streamlines Lung Cancer Diagnosis With Hybrid Operating Room

Carsten Schroeder, M.D., thoracic surgical oncologist at the Georgia Cancer Center and Medical College of Georgia at Augusta University in the hybrid OR. Image courtesy of Phil Jones, Senior Photographer, Augusta University

News | Lung Cancer | September 26, 2018
September 26, 2018 — When it comes to surviving cancer, early detection and treatment could be the key to a patient's
EOS Imaging Installs First Site in Mexico
News | Orthopedic Imaging | September 24, 2018
EOS imaging recently announced the first installation of an EOS system in Mexico, the largest Central American market,...